Every earnings call for SYNGENE — management tone, guidance, KPIs and promise tracking, quarter by quarter.
SYNGENE · 6 transcripts · Healthcare · latest Q4 FY26FY26 Operating EBITDA Margin 25%; FY26 PAT (before exceptional) ₹380 cr (−20% YoY). Q4 FY26 revenue from operations was INR 1,037 crores, reflecting 13% sequential growth.
Read full transcript & analysisQ3 Revenue from Operations ₹917 cr (−3% YoY); Q3 Operating EBITDA ₹209 cr; Q3 Operating EBITDA Margin 23%. Nine-month revenue from operations increased 3% year-on-year to Rs.2,702 crores.
Read full transcript & analysisRevenue from Operations ₹875 cr (+11% YoY); Operating EBITDA ₹206 cr (+21% YoY); EBITDA Margin 24%. Reported revenue from operations reached ₹875 crores, an 11% YoY increase (7% in constant currency).
Read full transcript & analysisRevenue ₹1,018 cr (+11% YoY); Operating EBITDA Margin 34%; PAT ₹183 cr (−3% YoY). Quarterly revenue from operations crossed ₹1,000 Cr for the first time, reaching ₹1,018 Cr (+11% YoY).
Read full transcript & analysisRevenue from Operations ₹944 cr (+11% YoY); Operating EBITDA ₹284 cr (+23% YoY); Operating EBITDA Margin 30.1%. Reported revenue from operations of ₹944 crores, up 11% YoY, marking a return to growth after two quarters of decline.
Read full transcript & analysisRevenue from Operations ₹891 cr (−2% YoY); Operating EBITDA ₹245 cr (−4% YoY); Operating EBITDA Margin 27.5%. Revenue from operations at ₹891 crores, down 2% YoY but up 13% sequentially.
Read full transcript & analysis